Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net ...

Female patients who deliver twins vs singletons are more apt to return to the hospital for CVD, especially during the first ...

A Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow chart detailing the selection process ... on NICM were halted early due to futility.6 7 In the Cardiomyopathy Trial ...

Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net cash provided by operating activities of $743 million in ...

The best dog food of 2025 includes wet, dry and grain-free dog food from brands like Purina, Royal Canin, The Farmer's Dog, ...

Peripartum cardiomyopathy (PPCM), a systolic dysfunction that occurs either in late pregnancy or in the early postpartum stage, is often misdiagnosed in the obstetric and primary care settings ...

Scotiabank analyst Greg Harrison raised the firm’s price target on BridgeBio (BBIO) to $49 from $48 and keeps an Outperform rating on the shares. BridgeBio recently announced its European partner ...

AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) ...

Capricor stock gains 8% upon completing the rolling submission of the BLA for its lead asset, deramiocel, to treat DMD cardiomyopathy in the United States. -If approved, deramiocel would be first ...

Five grants in the amount of $20,000 each were awarded this year to patient advocacy organizations serving the hypertrophic cardiomyopathy (HCM) and heart failure communities. The grants will ...

Bristol-Myers Squibb's Cobenfy launch shows strong initial sales and growth potential. Learn why BMY stock is a solid ...